Thread: Assessing the biosimilarity of protein drugs: New study shows method's precision - Phys.Org
View Single Post
  #1  
Unread 02-06-2016, 03:05 AM
nmrlearner's Avatar
nmrlearner nmrlearner is offline
Senior Member
  
Join Date: Jan 2005
Posts: 23,198
Points: 193,617, Level: 100
Points: 193,617, Level: 100 Points: 193,617, Level: 100 Points: 193,617, Level: 100
Level up: 0%, 0 Points needed
Level up: 0% Level up: 0% Level up: 0%
Activity: 50.7%
Activity: 50.7% Activity: 50.7% Activity: 50.7%
Last Achievements
Award-Showcase
NMR Credits: 0
NMR Points: 0
Downloads: 0
Uploads: 0
Default Assessing the biosimilarity of protein drugs: New study shows method's precision - Phys.Org
Assessing the biosimilarity of protein drugs: New study shows method's precision - Phys.Org


Phys.Org

Assessing the biosimilarity of protein drugs: New study shows method's precision
Phys.Org
Monoclonal antibodies are the largest class of approved protein therapeutics in the world, and the ability to extend 2D-NMR methods to this class of therapeutic would represent an important landmark in their analytical characterization. Thirty ...
Precision and robustness of 2D-NMR for structure assessment of filgrastim biosimilarsNature.com

all 5 news articles »
 Read here
Reply With Quote

Did you find this post helpful? Yes | No